Abstract:Rotavirus causes life-threatening diarrhea in children, resulting in ∼200,000 deaths/year. The current treatment during infection is Oral Rehydration Solution which successfully replenishes fluids but does not alleviate diarrhea volume or severity. As a result, there is an urgent need to better understand rotavirus pathophysiology and develop more effective pediatric therapeutics. Rotavirus primarily infects the tips of small intestinal villi, yet has far-reaching effects on cell types distant from infected cells. We recently identified that rotavirus infected cells release the purinergic signaling molecule ADP, which activates P2Y1 receptors on nearby uninfected cells . To elucidate the role of purinergic signaling via P2Y1 receptors during rotavirus infection , we used the mouse-like rotavirus strain D6/2 which generates a severe infection in mice. C57BL/6J mouse pups were given an oral gavage of D6/2 rotavirus and assessed over the course of 5-7 days. Beginning at day 1 post infection, infected pups were treated daily by oral gavage with saline or 4 mg/kg MRS2500, a selective P2Y1 antagonist. Mice were monitored for diarrhea severity, diarrhea incidence, and viral shedding. Neonatal mice were euthanized at days 3 and 5 post-infection and small intestine was collected to observe infection. MRS2500 treatment decreased the severity, prevalence, and incidence of rotavirus diarrhea. Viral stool shedding, assessed by qPCR for rotavirus gene levels, revealed that MRS2500 treated pups had significantly lower viral shedding starting at day 4 post infection compared to saline treated pups, which suggests P2Y1 signaling may enhance rotavirus replication. Finally, we found that inhibition of P2Y1 with MRS2500 limited transmitted rotavirus diarrhea to uninfected pups within a litter. Together, these results suggest that P2Y1 signaling is involved in the pathogenesis of a homologous murine rotavirus strain, making P2Y1 receptors a promising anti-diarrheal, anti-viral therapeutic target to reduce rotavirus disease burden.

Rotavirus induces intercellular calcium waves through ADP signaling

Viroporin activity from rotavirus nonstructural protein 4 induces intercellular calcium waves that contribute to pathogenesis

Pathogenesis of rotavirus gastroenteritis

Viraemia and Extraintestinal Involvement after Rotavirus Infection

Purinergic Signaling Drives Multiple Aspects of Rotavirus Pathophysiology

Rotavirus Interactions With Host Intestinal Epithelial Cells

Rotavirus-mediated DGAT1 degradation: A pathophysiological mechanism of viral-induced malabsorptive diarrhea

Rotavirus Sickness Symptoms: Manifestations of Defensive Responses from the Brain

Viral metagenomics of the gut virome of diarrheal children with Rotavirus A infection

Involvement of aquaporins in a mouse model of rotavirus diarrhea

Etiology of Severe Acute Watery Diarrhea in Children in the Global Rotavirus Surveillance Network Using Quantitative Polymerase Chain Reaction

Segmented Filamentous Bacteria Prevent and Cure Rotavirus Infection

Sodium Butyrate Protects Against Rotavirus-Induced Intestinal Epithelial Barrier Damage by Activating AMPK-Nrf2 Signaling Pathway in IPEC-J2 Cells

Host Cell Response to Rotavirus Infection with Emphasis on Virus–Glycan Interactions, Cholesterol Metabolism, and Innate Immunity

Crosstalk between imbalanced gut microbiota caused by antibiotic exposure and rotavirus replication in the intestine

ML241 Antagonizes ERK 1/2 Activation and Inhibits Rotavirus Proliferation

Microbiota-Derived Extracellular Vesicles as a Postbiotic Strategy to Alleviate Diarrhea and Enhance Immunity in Rotavirus-Infected Neonatal Rats

Rotavirus and Severe Childhood Diarrhea

Intestinal Innate Antiviral Immunity and Immunobiotics: Beneficial Effects against Rotavirus Infection

Bifidobacterium longum and Chlorella sorokiniana Combination Modulates IFN-γ, IL-10, and SOCS3 in Rotavirus-Infected Cells

The rotavirus VP5/VP8 conformational transition permeabilizes membranes to Ca2